Today's briefing covers a new antibody that cuts COPD flare-ups in two phase three trials, sobering global data on secondhand smoke exposure, and a meta-analysis showing how much weight returns after stopping GLP-1…
All episodes.
10 episodes. A 10‑minute briefing on the newest peer‑reviewed studies, every single day.
Today we cover a factor eleven-a inhibitor that cuts stroke recurrence without added bleeding risk, the first orthotopic pig liver transplant in a human, and new cardiac safety data on checkpoint inhibitors. We also…
In today's episode we cover six new studies: a monoclonal antibody that cuts COPD exacerbations, a real-world study on BTK inhibitor dosing in chronic lymphocytic leukemia, SGLT2 inhibitors in Fabry disease, a…
Today we cover a new European guideline on biliary stricture management, a meta-analysis of AI tools for sleep apnea screening, a Japanese safety signal linking levofloxacin to tendon injury, long-term data on the…
Today we cover a large network meta-analysis on exercise and bone health, two phase three trials of a new biologic for chronic obstructive pulmonary disease, and a global look at what puts flu patients at risk of…
Today we cover six new studies spanning oncology, hematology, and pulmonology. Highlights include psilocybin preventing chemotherapy nerve damage, a tumor antioxidant trick that blocks immune attack, a strong new…
Today we cover a new interleukin-thirty-three blocker that cuts COPD flare-ups, five-year survival data from the KEYNOTE-eight-twenty-six cervical cancer trial, real-world results for rimegepant in migraine, and a…
Today's briefing covers a major Australian trial on atorvastatin in older adults, the first complete wiring map of the male fruit fly nervous system, and a sweeping Nature review on treating fatty liver disease. We…
A daily briefing on new medical research for clinicians and curious minds. Today: how common hidden atherosclerosis is across adulthood, a major trial on statins in healthy older adults, the global burden of…
A daily briefing on new medical research for busy clinicians. Today: two practice-changing heart trials in the New England Journal of Medicine, a sobering look at how early silent artery disease begins, promising…